MLND News and Press, Millendo Therapeutics

Gainers: Entera Bio (ENTX) +56%. Orphazyme (ORPH) +47%. Bellerophon Therapeutics (BLPH) +26%. HUTCHMED (HCM) +11%. Evaxion Biotech (EVAX) +8%.Losers: Gemini Therapeutics (GMTX) -32%. Second Sight Medical Products (EYES) -19%. Millendo Therapeutics (MLND) -17...

Gemini Therapeutics (GMTX) -31% after initial data from mid-stage GEM103 AMD study.Second Sight Medical Products (EYES) -18% after secures $50M capital via equity raiseTorchlight Energy Resources (TRCH) -17%.Alfi (ALF) -16% stock pulls back from buyback-fueled ra...

SOUTH SAN FRANCISCO, Calif. and ANN ARBOR, Mich., June 22, 2021 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (“Tempest”), a clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted and immune-mediated mechanisms, and Mille...

NEW YORK, NY / ACCESSWIRE / May 25, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Ferro Corporation (NYSE:FOE) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relati...

NEW YORK, NY / ACCESSWIRE / May 13, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Nuance Communications, Inc. (NASDAQ: NUAN) concerning potential violations of the federal securities laws and/or breaches of fiduciary...

Shares of Millendo Therapeutics Inc. (NASDAQ:MLND) traded today at $0.93, breaking its 52-week low. So far today approximately 1.6 million shares have been exchanged, as compared to an average 30-day volume of 1 million shares. Over the past year, Millendo Therapeutics Inc. has traded in...

Shares of Millendo Therapeutics Inc. (NASDAQ:MLND) traded today at $0.97, breaking its 52-week low. So far today approximately 1.6 million shares have been exchanged, as compared to an average 30-day volume of 1 million shares. Millendo Therapeutics Inc is a late-stage biopharmaceutical ...

Shares of Millendo Therapeutics Inc. (NASDAQ:MLND) traded at a new 52-week low today of $1.05. Approximately 1.6 million shares have changed hands today, as compared to an average 30-day volume of 1 million shares. Millendo Therapeutics Inc. (NASDAQ:MLND) has potential upside of 10.3% ba...

Millendo Therapeutics Inc. (NASDAQ:MLND) traded today at a new 52-week low of $1.08. So far today approximately 1.6 million shares have been exchanged, as compared to an average 30-day volume of 1 million shares. In the past 52 weeks, shares of Millendo Therapeutics Inc. have traded betw...

Will These Penny Stocks Keep Climbing In April? Penny stocks are starting to heat up again. The last few weeks were touch and go as markets tried to figure out which direction they wanted to head. Concerns over inflation and rates combated by upbeat sentiment about stimulus and the reop...